Prevention of anaphylactic reactions to anaesthetic drugs

Drug Safety

Volumn 27, Issue 6, 2004, Pages 393-410

  Fisher, Malcolm M ^a,b   Doig, Gordon S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCURONIUM; AMMONIUM DERIVATIVE; ANTIHISTAMINIC AGENT; AZTREONAM; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEPHALOSPORIN; CORTICOSTEROID; COSMETIC; DEXTRAN; DIPHENHYDRAMINE; EPHEDRINE; FELYPRESSIN; FENTANYL; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; ISOPHANE INSULIN; LATEX; MIDAZOLAM; MONOBACTAM DERIVATIVE; MORPHINE; PANCURONIUM BROMIDE; PENICILLIN G; PRILOCAINE; PROTAMINE SULFATE; ROCURONIUM; SODIUM METABISULFITE; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG;

ALLERGY; ANALYTIC METHOD; ANAMNESIS; ANAPHYLAXIS; ATOPY; CHRONIC FATIGUE SYNDROME; DESENSITIZATION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EXPOSURE; EGG; FAMILY HISTORY; FISH; FOLLOW UP; FOOD ALLERGY; HUMAN; INCIDENCE; MULTIPLE CHEMICAL SENSITIVITY; NERVE BLOCK; NEUROMUSCULAR BLOCKING; POPULATION RESEARCH; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCREENING TEST; SEX DIFFERENCE; SPINA BIFIDA; VALIDATION PROCESS; VASECTOMY;

ANAPHYLAXIS; ANESTHESIA; ANESTHETICS; CLINICAL TRIALS; HUMANS; RISK FACTORS;

EID: 2342534953     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200427060-00004     Document Type: Review

References (104)

1. Porter J, Jick H. Drug-related deaths among medical inpatients. JAMA 1977; 237: 879-81
2. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993; 12: 97-104
3. Laxenaire MC, Mertes PM, Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques. Anaphylaxis during anaesthesia: results of a two-year survey in France. Br J Anaesth 2001; 87: 549-58
4. Societe Francaises d'Anesthesie et de Reanimation. Reducing the risk of anaphylaxis during anaesthesia. Ann Fr Anesth Reanim 2002; 21 Suppl. 1: 7S-23S
5. Assem ES. Anaphylactic anaesthetic reactions: the value of paper radioallergosorbent tests for IgE antibodies to muscle relaxants and thiopentone. Anaesthesia 1990; 45: 1032-8
6. Noble DW, Yap PL. Screening for antibodies to anaesthetics [editorial]. BMJ 1989; 299: 2
7. Whitby LG. Definitions and criteria: screening for disease. Lancet 1974; II: 3-5
8. Watkins J. Skin testing and the anaesthetist. Br J Anaesth 2000; 85: 814-7
9. Plaud B, Donati F, Debaene B. Anaphylaxis during anaesthesia. Br J Anaesth 2002; 88 (4): 604-5
10. Fisher M, Baldo BA. Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesth 1994; 11 (4): 263-84
11. Fisher MM, Baldo BA. Persistence of allergy to anaesthetic drugs. Anaesth Intensive Care 1992; 20: 143-6
12. Beemer GH, Dennis WL, Platt PR, et al. Adverse reactions to atracurium and alcuronium: a prospective surveillance survey. Br J Anaesth 1988; 61: 680-4
13. Porri F, Pradal M, Rud C, et al. Is systematic preoperative screening for muscle relaxant and latex allergy advisable? Allergy 1995; 50 (4): 374-7
14. Porri F, Lemiere C, Birnbaum J, et al. Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy 1999; 29 (1): 72-5
15. Maria Y, Grosdidier R, Haberer JP, et al. Prospective preoperative survey of 300 patients using prick tests with muscle relaxants [in French]. Ann Fr Anesth Reanim 1989; 8 (4): 301-5
16. Fisher MM, Munro I. Life-threatening anaphylactoid reactions to muscle relaxants. Anesth Analg 1983; 62: 559-64
17. Harle DG, Baldo BA, Fisher MM. Assays for, and cross-reactivities of, IgE antibodies to the muscle relaxants gallamine, decamethonium and succinylcholine (suxamethonium). J Immunol Methods 1985; 78 (2): 293-305
18. Moneret-Vautrin DA, Gueant JL, Kamel L, et al. Anaphylaxis to muscle relaxants: cross-sensitivity studied by radioimmuno-assays compared to intradermal tests in 34 cases. J Allergy Clin Immunol 1988; 82: 745-52
19. Thacker MA, Davis FM. Subsequent general anaesthesia in patients with a history of previous anaphylactoid/anaphylactic reaction to muscle relaxant. Anaesth Intensive Care 1999; 27 (2): 190-3
20. Fisher MM, Merefield D, Baldo B. Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia. Br J Anaesth 1999; 82 (5): 770-3
21. Bernardini R, Novembre E, Lombardi E, et al. Risk factors for latex allergy in patients with spina bifida and latex sensitization. Clin Exp Allergy 1999; 29 (5): 681-6
22. Leynadier F, Pecquet C, Dry J. Anaphylaxis to latex during surgery. Anaesthesia 1989; 44: 547-50
23. Condemi JJ. Allergic reactions to natural rubber latex at home, to rubber products, and to cross-reacting foods. J Allergy Clin Immunol 2002; 110 (2 Suppl.): S107-10
24. Levy DA, Mounedji N, Noirot C, et al. Allergic sensitization and clinical reactions to latex, food and pollen in adult patients. Clin Exp Allergy 2000; 30 (2): 270-5
25. Beezhold DH, Sussman GL, Liss GM, et al. Latex allergy can induce clinical reactions to specific foods. Clin Exp Allergy 1996; 26 (4): 416-22
26. Garcia Ortiz JC, Moyano JC, Alvarez M, et al. Latex allergy in fruit-allergic patients. Allergy 1998; 53 (5): 532-6
27. Freeman GL. Cooccurrence of latex and fruit allergies. Allergy Asthma Proc 1997; 18 (2): 85-8
28. Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol 2001; 108 (6): 881-90
29. Nettis E, Assennato G, Ferrannini A, et al. Type I allergy to natural rubber latex and type IV allergy to rubber chemicals in health care workers with glove-related skin symptoms. Clin Exp Allergy 2002; 32 (3): 441-7
30. Arellano R, Bradley J, Sussman G. Prevalence of latex sensitization among hospital physicians occupationally exposed to latex gloves. Anesthesiology 1992; 77: 905-8
31. Katelaris CH, Widmer RP, Lazarus RM, et al. Screening for latex allergy with a questionnaire: comparison with latex skin testing in a group of dental professionals. Aust Dent J 2002; 47 (2): 152-5
32. Fisher MM. Latex allergy during anaesthesia: cautionary tales. Anaesth Intensive Care 1997; 25 (3): 302-3
33. Hepner DL, Castells MC. Latex allergy: an update. Anesth Analg 2003; 96 (4): 1219-29
34. Hamilton RG, Peterson EL, Ownby DR. Clinical and laboratory-based methods in the diagnosis of natural rubber latex allergy. J Allergy Clin Immunol 2002; 110 (2 Suppl.): S47-56
35. Cremer R, Kleine-Diepenbruck U, Hoppe A, et al. Latex allergy in spina bifida patients: prevention by primary prophylaxis. Allergy 1998; 53 (7): 709-11
36. Nieto A, Mazon A, Pamies R, et al. Efficacy of latex avoidance for primary prevention of latex sensitization in children with spina bifida. J Pediatr 2002; 140 (3): 370-2
37. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995 Feb; 74 (2): 167-70
38. Baldo BA. Penicillins and cephalosporins as allergens: structural aspects of recognition and cross-reactions. Clin Exp Allergy 1999; 29 (6): 744-9
39. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001; 345 (11): 804-9
40. Hung OR, Bands C, Laney G, et al. Drug allergies in the surgical population. Can J Anaesth 1994; 41 (12): 1149-55
41. Salkind AR, Cuddy PG, Foxworth JW. The rational clinical examination: is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA 2001 May 16; 285: 2498-505
42. Goodman EJ, Morgan MJ, Johnson PA, et al. Cephalosporins can be given to penicillin-allergic patients who do not exhibit an anaphylactic response. J Clin Anesth 2001; 13 (8): 561-4
43. Novalbos A, Sastre J, Cuesta J, et al. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy 2001; 31 (3): 438-43
44. Kishiyama JL, Adelman DC. The cross-reactivity and immunology of beta-lactam antibiotics. Drug Saf 1994; 10 (4): 318-27
45. Soulat JM, Bouju P, Oxeda C, et al. Anaphylactoid shock due to metabisulfites during cesarean section under peridural anesthesia. Can Anesthesiol 1991; 39: 257-9
46. Kajimoto Y, Rosenberg ME, Kytta J, et al. Anaphylactoid skin reactions after intravenous regional anaesthesia using 0.5% prilocaine with or without preservative: a double-blind study. Acta Anaesthesiol Scand 1995; 39 (6): 782-4
47. Fisher MM, Bowey CJ. Alleged allergy to local anaesthetics. Anaesth Intensive Care 1997; 25 (6): 611-4
48. Kelso JM. The gelatin story. J Allergy Clin Immunol 1999; 103 (2 Pt 1): 200-2
49. Clark MM, Cockburn HA. Anaphylactoid response to thiopentone. Br J Anaesth 1971; 43: 185-9
50. Baldo BA, Fisher MM, Harle DG. Allergy to thiopentone. Clin Rev Allergy 1991; 9: 295-308
51. Weiler JM, Gellhaus MA, Carter JG, et al. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery. J Allergy Clin Immunol 1990; 85 (4): 713-9
52. Weiss ME, Adkinson Jr NF. Allergy to protamine. Clin Rev Allergy 1991; 9 (3-4): 339-55
53. Adourian U, Shampaine EL, Hirshman CA, et al. High-titer protamine-specific IgG antibody associated with anaphylaxis: report of a case and quantitative analysis of antibody in vasectomized men. Anesthesiology 1993; 78 (2): 368-72
54. Vezina D, Sheridan P, Blain R, et al. Safety of protamine sulfate administration in vasectomized men. Contraception 1990; 41 (6): 605-16
55. Vincent GM, Janowski M, Menlove R. Protamine allergy reactions during cardiac catheterization and cardiac surgery: risk in patients taking protamine-insulin preparations. Cathet Cardiovasc Diagn 1991; 23 (3): 164-8
56. Levy JH, Schwieger IM, Zaidan JR, et al. Evaluation of patients at risk for protamine reactions. J Thorac Cardiovasc Surg 1989 Aug; 98 (2): 200-4
57. Hofer KN, McCarthy MW, Buck ML, et al. Possible anaphylaxis after propofol in a child with food allergy. Ann Pharmacother 2003; 37 (3): 39-401
58. Laxenaire M, Mata-Bermejo E, Moneret-Vautrin D, et al. Life-threatening anaphylactoid reactions to propofol (Diprivan). Anesthesiology 1992; 77: 275-80
59. Harle DG, Baldo BA, Fisher MM. The molecular basis of Ige antibody binding to thiopentone: binding of Ige from thiopentone-allergic and non-allergic subjects. Mol Immunol 1990; 27: 853-8
60. Fisher MM, Baldo BA. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 2000; 28 (2): 167-70
61. Pepys J, Pepys EO, Baldo BA, et al. Anaphylactic/anaphylactold reactions to anaesthetic and associated agents: skin prick tests in aetiological diagnosis. Anaesthesia 1994; 49 (6): 470-5
62. Laxenaire MC, Moneret-Vautrin DA, Vervloet D. The French experience of anaphylactoid reactions. Int Anesthesiol Clin 1985; 23: 145-60
63. Galletly DC, Treuren BC. Anaphylactoid reactions during anaesthesia: seven years' experience of intradermal testing. Anaesthesia 1985; 40: 329-33
64. Fisher MM. Anaphylaxis to anaesthetic drugs: aetiology, recognition and management. Curr Anaesth Crit Care 1991; 2: 182-6
65. Laforest M, More D, Fisher M. Predisposing factors in anaphylactoid reactions to anaesthetic drugs in an Australian population: the role of allergy, atopy and previous anaesthesia. Anaesth Intensive Care 1980; 8: 454-9
66. Duvaldestin P, Wigdorowicz C, Gabriel I. Anaphylactic shock to neuromuscular blocking agent: a familial history. Anesthesiology 1999; 90: 1211-2
67. Fee JPH, Mcdonald JR, Clarke RSJ, et al. Incidence of atopy and allergy in 10000 preanaesthetic patients. Br J Anaesth 1979; 50: 74-8
68. Moneret-Vautrin DA, Grilliat JP, Laxenaire MC, et al. The risk factors of anaphylactoid accidents in general anesthetics and auxiliary substances (author's transl). Therapie 1980; 35: 335-40
69. Fisher MM, Outhred A, Bowey CJ. Can clinical anaphylaxis to anaesthetic drugs be predicted from allergic history? Br J Anaesth 1987; 59: 690-2
70. Charpin D, Benzarti M, Hemon Y, et al. Atopy and anaphylactic reactions to suxamethonium. J Allergy Clin Immunol 1988; 82: 356-60
71. Kipen HM, Fiedler N. Environmental factors in medically unexplained symptoms and related syndromes: the evidence and the challenge. Environ Health Perspect 2002; 110 Suppl. 4: 597-9
72. Engel Jr CC, Adkins JA, Cowan DN. Caring for medically unexplained physical symptoms after toxic environmental exposures: effects of contested causation. Environ Health Perspect 2002; 110 Suppl. 4: 641-7
73. Fisher M. Intradermal testing after anaphylactoid reaction to anaesthetic drugs: practical aspects of performance and interpretation. Anaesth Intensive Care 1984; 12: 115-20
74. Leynadier F, Sansarricq M, Didier JM, et al. Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 1987; 59: 683-9
75. Thacker MA, Gibbs JM. A hypersensitivity screening clinic following untoward reactions to anaesthesia. N Z Med J 1984; 97: 232-4
76. Moneret-Vautrin DA, Laxenaire MC, Widmer S, et al. The value of prick tests in the detection of anaphylaxis caused by muscle relaxants. Ann Fr Anesth Reanim 1987; 6: 352-5
77. Grange C, Fisher M, Baldo BA. Allergy testing after uneventful anaesthesia. Anaesth Intensive Care 1993; 21: 124
78. Gueant JL, Masson C, Laxenaire MC. Biological tests for diagnosing the IgE-mediated allergy to anesthetic drugs. Monogr Allergy 1992; 30: 94-107
79. Gueant JL, Mata E, Monin B, et al. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxants. Allergy 1991; 46: 452-8
80. Baldo BA, Harle DG, Fisher MM. In vitro diagnosis and studies on the mechanism (s) of anaphylactoid reactions to muscle relaxant drugs. Ann Fr Anesth Reanim 1985; 4: 139-45
81. Harle DG, Baldo BA, Fisher MM. Detection of IgE antibodies to suxamethonium after anaphylactoid reactions during anaesthesia. Lancet 1984; I: 930-2
82. Harle DG, Baldo BA, Smal MA, et al. Detection of thiopentone-reactive IgE antibodies following anaphylactoid reactions during anaesthesia. Clin Allergy 1986; 16: 493-8
83. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998; 80: 26-9
84. Moscicki RA, Sockin SM, Corsello BF, et al. Anaphylaxis during induction of general anesthesia: subsequent evaluation and management. J Allergy Clin Immunol 1990; 86: 325-32
85. Fisher MM. The prevention of second anaphylactoid reactions to anaesthetic drugs. Anaesth Intensive Care 1981; 9: 242-7
86. Conil C, Bornet JL, Jean-Noel M, et al. Anaphylactic shock caused by pancuronium and vecuronium. Ann Fr Anesth Reanim 1985; 4: 241-3
87. Moneret-Vautrin DA, Widmer S, Gueant JL, et al. Simultaneous anaphylaxis to thiopentone and a neuromuscular blocker: a study of two cases. Br J Anaesth 1990; 64: 743-5
88. Fisher MM, Bowey CJ. Intradermal versus prick testing in the diagnosis of anaesthic allergy: a prospective study. Br J Anaesth 1997 Jul; 79 (1): 59-63
89. Schwartz LB, Yunginger JW, Miller J, et al. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989; 83: 1551-5
90. Laroche D, Vergnaud MC, Sillard B, et al. Biochemical markers of anaphylactoid reactions to drugs: comparison of plasma histamine and tryptase. Anesthesiology 1991; 75: 945-9
91. Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001; 86: 678-82
92. Laake JH, Rottingen JA. Rocuronium and anaphylaxis: a statistical challenge. Acta Anaesthesiol Scand 2001; 45: 1196-203
93. Lieberman P. The use of antihistamines in the prevention and treatment of anaphylaxis and anaphylactoid reactions. J Allergy Clin Immunol 1990; 86: 684-6
94. Philbin DM, Moss J, Akins CW, et al. The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study. Anesthesiology 1981; 55: 292-6
95. Lorenz W, Doenicke A. H1 and H2 blockade: a prophylactic principle in anaesthesia and surgery against histamine-release responses of any degree of severity: Part II. N Engl Reg Allergy Proc 1985; 6: 174-94
96. Lorenz W, Duda D, Dick W, et al. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Lancet 1994; 343: 933-9
97. Moss J, Rosow CE. Histamine release by narcotics and muscle relaxants in humans. Anesthesiology 1983; 59: 330-9
98. Moss J. Use of prophylactic combined H1 and H2 antagonists reduces mortality in chymopapain anaphylaxis. Ann Fr Anesth Reanim 1985; 4: 221-4
99. Ljungstrom KG, Willman B, Hedin H. Hapten inhibition of dextran anaphylaxis: nine years of post-marketing surveillance of dextran 1. Ann Fr Anesth Reanim 1993; 12: 219-22
100. Baldo BA, Fisher MM. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983; 306: 262-4
101. Thomas H, Eledjam JJ, Macheboeuf M, et al. Rapid pre-operative immunotherapy in a patient allergic to muscle relaxants. Eur J Anaesth 1988; 5: 385-9
102. Moneret-Vautrin DA, Widmer S, Gueant JL, et al. Protective effect of a monovalent haptene: tiemonium methylsulfate on anaphylaxis from myorelaxants: preliminary results (in French) [abstract]. Ann Fr Anesth Reanim 1989 1908, R133
103. Moneret-Vautrin DA, Kanny G, Gueant JL, et al. Prevention by monovalent haptens of IgE-dependent leucocyte histamine release to muscle relaxants. Int Arch Allergy Immunol 1995; 107: 172-5
104. Soetens FM, Smolders FJ, Meeuwis HC, et al. Intradermal skin testing in the investigation of suspected anaphylactic reactions during anaesthesia: a retrospective survey. Acta Anaesthesiologica Belgica 2003; 54: 59-63